Effectiveness and Safety of Isavuconazole Compared with Posaconazole as Primary Antifungal Prophylaxis in High-risk Neutropenic Patients with Hematologic Malignancies and Allogeneic Hematopoietic Cell Transplantation (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 1378; Pres time: Oct 24, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available
Clinical • Infectious Disease
|
|
Fabián Herrera, Medical Doctor (he/him/his); Diego Torres, Medical Doctor; Noelia Mañez, n/a; Rosana Jordán, Medical Doctor; José Benso, Medical Doctor; Manuel Angel Alderete, Sr., Medico; Natalia GARCIA ALLENDE, MD; Gustavo A. Mendez, Sr., MD (he/him/his); María L. Pereyra, n/a; Lucas Tula, Medical Doctor; Adriana Manzur, n/a; Hugo I. Peretti, El, Medico; Claudia Salgueira, MD; Mariana Rodríguez Raimondo, Infectious Diseases Specialist; Florencia Indo, MD; Silvina García Rojas, Coautor; Paula Calello, n/a; Maximiliano Gabriel Castro, Internal Medicine Specialist; Verónica Fernández, n/a; Agustina RISSO PATRON, MD; Carla Niveyro, MD (she/her/hers); Rocío Gago, n/a; L. Agustin Luengo Ackermann, MD; Javier Afeltra, Md/PhD
|